Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
CGEM holding history
Cullinan Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CGEM overviewAll 13F holders of CGEMFull Q1 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −31,853−100.0% | Sold out | Holders |
| Q2 2025 | 31,853 | $239.9K | <0.1% | −11,554−26.6% | Reduced | Holders |
| Q1 2025 | 43,407 | $328.6K | <0.1% | −295−0.7% | Reduced | Holders |
| Q4 2024 | 43,702 | $532.3K | 0.1% | +9,165+26.5% | Added | Holders |
| Q3 2024 | 34,537 | $578.1K | 0.1% | +21,412+163.1% | Added | Holders |
| Q2 2024 | 13,125 | $228.9K | <0.1% | −11,528−46.8% | Reduced | Holders |
| Q1 2024 | 24,653 | $420.1K | 0.1% | +24,653 | New | Holders |